JY
LFCR icon

Jeff Yass’s Lifecore Biomedical LFCR Stock Holding History

Jeff Yass’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
+31,700
New +$160K ﹤0.01% 12119
2026
Q1 		– Sell
-16,500
Closed -$135K – 13683
2025
Q4 		$135K Buy
+16,500
New +$122K ﹤0.01% 11254
2025
Q1 		– Sell
-31,500
Closed -$234K – 13034
2024
Q4 		$234K Sell
31,500
-34,300
-52% -$219K ﹤0.01% 10363
2024
Q3 		$324K Buy
65,800
+7,800
+13% +$40.7K ﹤0.01% 9437
2024
Q2 		$298K Sell
58,000
-25,700
-31% -$152K ﹤0.01% 9467
2024
Q1 		$444K Buy
83,700
+17,600
+27% +$126K ﹤0.01% 8796
2023
Q4 		$409K Buy
66,100
+20,400
+45% +$142K ﹤0.01% 9133
2023
Q3 		$345K Sell
45,700
-23,300
-34% -$213K ﹤0.01% 9051
2023
Q2 		$667K Buy
+69,000
New +$421K ﹤0.01% 7631
2018
Q2 		– Sell
-14,000
Closed -$183K – 10028
2018
Q1 		$183K Buy
+14,000
New +$184K ﹤0.01% 8386
2017
Q4 		– Sell
-16,900
Closed -$219K – 9614
2017
Q3 		$219K Sell
16,900
-5,900
-26% -$77.8K ﹤0.01% 7877
2017
Q2 		$339K Buy
+22,800
New +$317K ﹤0.01% 7350
2017
Q1 		– Sell
-16,000
Closed -$221K – 9485
2016
Q4 		$221K Sell
16,000
-6,200
-28% -$85.9K ﹤0.01% 8509
2016
Q3 		$298K Buy
+22,200
New +$269K ﹤0.01% 6941
2015
Q4 		– Sell
-12,600
Closed -$147K – 9711
2015
Q3 		$147K Buy
+12,600
New +$167K ﹤0.01% 8935
2015
Q2 		– Sell
-10,200
Closed -$142K – 10286
2015
Q1 		$142K Buy
+10,200
New +$141K ﹤0.01% 8829

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jeff Yass's LFCR Position: Q2 2026 in Review

Jeff Yass sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 40,789 shares — an estimated $205K sold.

Jeff Yass first reported a position in LFCR in Q3 2013 and held it in 25 quarters. The position peaked at $3.16M in Q2 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Jeff Yass reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 40,789 Lifecore Biomedical shares in Q2 2026, an estimated $205K.
  • Jeff Yass first reported a position in Lifecore Biomedical in Q3 2013 and held it in 25 quarters.
  • Jeff Yass's Lifecore Biomedical position peaked at $3.16M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.